Company / Revenue per Share
Collegium Pharmaceutical, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$24.62
FY2025
5-year range
$8.23 / $24.62
FY2021-FY2025
Trend
+22.6%
vs FY2024
Sector context
#21 of 154
Health Care
What the data says
Collegium Pharmaceutical, Inc.'s revenue per share of $24.62 is higher than 86% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 4 consecutive years, from $8.23 in FY2021 to $24.62 in FY2025.
Based on SEC 10-K filings.
24.62 in FY2025 with a 5-year CAGR of +22.4%. Top quartile in the Health Care sector.
Improved from $17.78 to $24.62 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +21.6%
- 5-Year CAGR
- +22.4%
- 10-Year CAGR
- -
Sector benchmark
+64.3% above sector average
Key checks
Key Insights
- Collegium Pharmaceutical, Inc.'s revenue per share has grown for 4 consecutive years.
- In FY2025, revenue per share increased 22.6% year-over-year.
- Ranks #21 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $24.62 | +22.6% |
| FY2024 | $20.08 | +12.9% |
| FY2023 | $17.78 | +29.8% |
| FY2022 | $13.71 | +66.6% |
| FY2021 | $8.23 | -8.2% |
| FY2020 | $8.96 | +0.4% |
| FY2019 | $8.92 | +4.2% |
| FY2018 | $8.56 | +14585.2% |
| FY2017 | $0.06 | -29.4% |
| FY2016 | $0.08 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026